PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9916491-2 1998 Luminol-dependent Chemiluminescence (LmCL) responses were inhibited by a high concentration of IFN-alpha (more than 1 x 10(4) IU/ml) when opsonized zymosan (OZ) and phorbol 12-myristate 13-acetate (PMA) were used as stimulants. Zymosan 148-155 interferon alpha 1 Homo sapiens 95-104 18256754-1 2007 The production of TNF-alpha and IFN-alpha cytokines by peripheral blood mononuclears in response to stimulation by TLR2/6, TLR4, TLR5, TLR9 ligands (zymosan, LPS, flagellin, and CpG-oligodeoxynucleotide, respectively) was studied in donors and patients with common variable immunodeficiency. Zymosan 149-156 interferon alpha 1 Homo sapiens 32-41 17927969-4 2007 Here we report that monocyte-derived dendritic cells (MoDCs) combine and integrate signals received via the IFN-dependent pathway by engagement of TLR3 (poly I:C) and activation of TRIF with the MyD88-dependent pathway by ligation of TLR2 (PGN), TLR2/TLR6 (zymosan) and TLR5 (flagellin). Zymosan 257-264 interferon alpha 1 Homo sapiens 108-111 8938568-4 1996 However, when present on both sides of the micropore membrane, all the IFN (1000 U/ml IFN-alpha and IFN-beta, 100 U/ml IFN-gamma) inhibited both random and directed migration toward zymosan-activated serum (ZAS). Zymosan 182-189 interferon alpha 1 Homo sapiens 86-95 9266926-1 1997 The eosinophil activity in patients with renal cell adenocarcinoma during treatment with interleukin-2 (IL-2) and interferon-alpha (IFN-alpha) was reduced when measured as zymosan-induced lucigenin-enhanced chemiluminescence (CL). Zymosan 172-179 interferon alpha 1 Homo sapiens 132-141 3585077-7 1987 Therefore, enhanced CL reactivity to PMA or Zymosan observed in the whole blood of the patients" population appears to be due to the presence of interferon in serum blood components as a consequence of IFN-infusion rather than to other symptoms or treatments of the neoplastic diseases, since the relative CL enhancement in patients is abrogated when isolated blood leukocytes are used for CL assay. Zymosan 44-51 interferon alpha 1 Homo sapiens 202-205 3090949-6 1986 When PMN were incubated with IFN gamma for 1 h and then stimulated with chemotactic peptide f-met-phe (FMP), zymosan-activated serum (ZAS), zymosan particles, or phorbol-myristate acetate (PMA), the CL response was increased as consequence of the generally enhanced oxidative metabolism. Zymosan 109-116 interferon alpha 1 Homo sapiens 29-32